share_log

Morgan Stanley Maintains Overweight on SI-BONE, Lowers Price Target to $21

Benzinga ·  Jul 16 00:55

Morgan Stanley analyst Drew Ranieri maintains SI-BONE (NASDAQ:SIBN) with a Overweight and lowers the price target from $25 to $21.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment